Orthobiologics Market Size, Trends and Forecast to 2023-28 from rocky rai's blog

IMARC Group, a leading market research company, has recently releases report titled “Orthobiologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global orthobiologics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

The global orthobiologics market size reached US$ 5.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2023-2028.

Orthobiologics are prescription drugs made by living organisms to heal orthopedic tissues. Some of the common ortho-biologics include bone marrow concentrate, platelet-rich plasma (PRP), birth tissues and certain fat grafts. These are autologous or allogeneic substances that are injected or placed surgically to accelerate the healing of bones, joints, muscles, or tendons. Nowadays, platelet-rich plasma (PRP) is a rapidly gaining traction in the field of regenerative medicine, showing excellent potential in triggering or expediting the healing process in bones, muscles and ligaments.

Request for a free sample copy of this report: https://www.imarcgroup.com/orthobiologics-market/requestsample

The market is primarily driven by the increasing prevalence of osteoarthritis(OA), especially among the geriatric population. Older adults are also highly susceptible to spinal and other orthopedic disorders, resulting in the need for an increased number of orthopedic procedures. Besides this, the rising awareness among physicians and patients about the benefits of orthobiologic therapies and newly introduced treatment procedures and technologies have encouraged them to opt for orthobiologics. Moreover, extensive investments and collaborations by prominent medical device and biotechnology companies in the research and development (R&D) to produce advanced orthobiologics are providing a positive market outlook. Some of the other factors, including the growing preference for minimally invasive (MI) procedures, improving healthcare infrastructure and the advent of next-generation biologics technology, are also contributing to the market growth.

The report has segmented the market into the following categories:

Breakup by Product:

• Demineralized Bone Matrix
• Allograft
• Bone Morphogenetic Protein
• Viscosupplementation Products
• Synthetic Bone Substitutes
• Others 

Breakup by Type:

• Knee
• Ankle
• Hip
• Wrist and Shoulder
• Spine
• Others

Breakup by Application:

• Osteoarthritis and Degenerative Arthritis
• Spinal Fusion
• Fracture Recovery
• Soft Tissue Injuries
• Maxillofacial and Dental Applications

Breakup by End User:

• Hospitals and Ambulatory Centers
• Research and Academic Institutes
• Dental Clinics and Facilities
• Orthopedic Clinics

Breakup by Region:

North America (U.S. & Canada)

Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)

Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)

Latin America (Brazil, Mexico)

Middle East & Africa

The report covers the major market players including:

• Arthrex Inc
• Globus Medical Inc.
• Integra LifeSciences
• Johnson & Johnson
• Medline Industries Inc.
• Medtronic plc
• NuVasive Inc
• Orthofix Medical Inc.
• Smith & Nephew plc
• Stryker Corporation
• Terumo Corporation
• Wright Medical Group N.V.
• Zimmer Biomet

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4332&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/